Catalyst Pharmaceuticals (CPRX) Free Cash Flow (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.77% |
| Dec 31, 2025 | 38.29% |
| Sep 30, 2025 | -54.49% |
| Jun 30, 2025 | 18.70% |
| Mar 31, 2025 | -15.18% |
| Dec 31, 2024 | -2.51% |
| Sep 30, 2024 | 13.24% |
| Jun 30, 2024 | 102.12% |
| Mar 31, 2024 | -42.89% |
| Dec 31, 2023 | 23.28% |
| Sep 30, 2023 | 46.53% |
| Jun 30, 2023 | 156.37% |
| Mar 31, 2023 | -70.07% |
| Dec 31, 2022 | -2.96% |
| Sep 30, 2022 | 57.69% |
| Jun 30, 2022 | 208.93% |
| Mar 31, 2022 | -55.69% |
| Dec 31, 2021 | -11.57% |
| Sep 30, 2021 | 38.06% |
| Jun 30, 2021 | 439.92% |
| Mar 31, 2021 | -77.85% |
| Dec 31, 2020 | 14.44% |
| Sep 30, 2020 | -13.68% |
| Jun 30, 2020 | 83.90% |
| Mar 31, 2020 | -41.32% |
| Dec 31, 2019 | -24.41% |
| Sep 30, 2019 | 15.66% |
| Jun 30, 2019 | 275.27% |
| Mar 31, 2019 | 4.59% |
| Dec 31, 2018 | -20.53% |
| Sep 30, 2018 | -46.14% |
| Jun 30, 2018 | 21.51% |
| Mar 31, 2018 | -50.91% |
| Dec 31, 2017 | -53.06% |
| Sep 30, 2017 | 17.75% |
| Jun 30, 2017 | 17.48% |
| Mar 31, 2017 | 12.22% |
| Dec 31, 2016 | -34.80% |
| Sep 30, 2016 | 24.53% |
| Jun 30, 2016 | 26.76% |
| Mar 31, 2016 | -28.05% |
| Dec 31, 2015 | 13.56% |
| Sep 30, 2015 | -26.15% |
| Jun 30, 2015 | -11.68% |
| Mar 31, 2015 | 4.78% |
| Dec 31, 2014 | -12.00% |
| Sep 30, 2014 | -18.99% |
| Jun 30, 2014 | -22.70% |
| Mar 31, 2014 | 40.87% |
| Dec 31, 2013 | -145.27% |
| Sep 30, 2013 | 7.08% |
| Jun 30, 2013 | 19.76% |
| Mar 31, 2013 | -37.78% |
| Dec 31, 2012 | -48.90% |
| Sep 30, 2012 | 3.95% |
| Jun 30, 2012 | 12.25% |
| Mar 31, 2012 | 9.29% |
| Dec 31, 2011 | -14.96% |
| Sep 30, 2011 | 14.38% |
| Jun 30, 2011 | -76.04% |
| Mar 31, 2011 | -8.06% |
| Dec 31, 2010 | 5.90% |